<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Goserelin</title><link>https://peptidescanner.com/peptides/goserelin/</link><description>Versioned, source-linked PeptideScanner evidence objects for Goserelin. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/goserelin.xml" rel="self" type="application/rss+xml"/><item><title>ClinicalTrials.gov record NCT00004124</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00004124-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00004124-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00004124-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2022-12-30. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00005044</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00005044-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00005044-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00005044-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2022-06-15. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00108732</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00108732-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00108732-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00108732-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2015-06-30. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00114114</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00114114-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00114114-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00114114-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2019-10-08. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00186121</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00186121-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00186121-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00186121-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2019-10-07. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00283803</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00283803-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00283803-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00283803-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2018-08-07. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00295646</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00295646-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00295646-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00295646-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2024-03-15. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00322348</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00322348-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00322348-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00322348-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2011-01-24. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00328614</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00328614-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00328614-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00328614-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2025-05-16. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00432172</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00432172-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00432172-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00432172-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2023-04-03. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00586898</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00586898-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00586898-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00586898-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2016-03-25. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00605267</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00605267-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00605267-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct00605267-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2012-09-06. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01073865</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01073865-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01073865-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct01073865-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2018-12-12. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01250717</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01250717-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01250717-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct01250717-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2014-02-04. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01496131</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01496131-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01496131-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct01496131-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2018-03-09. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01682642</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01682642-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01682642-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct01682642-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2015-03-20. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01723774</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01723774-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01723774-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct01723774-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-09-25. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02003209</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02003209-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02003209-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct02003209-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-10-06. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02115282</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02115282-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02115282-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct02115282-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-10-22. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02278120</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02278120-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02278120-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct02278120-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2024-03-12. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02430480</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02430480-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02430480-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct02430480-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2025-07-16. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02518191</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02518191-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02518191-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct02518191-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-06-11. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02586675</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02586675-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02586675-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct02586675-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2022-01-21. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03007979</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03007979-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03007979-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct03007979-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2024-03-20. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03096847</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03096847-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03096847-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct03096847-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-10-11. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03671330</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03671330-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03671330-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct03671330-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-07-08. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03822468</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03822468-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03822468-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct03822468-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2025-10-16. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03839823</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03839823-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03839823-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct03839823-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2024-10-09. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT05161195</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct05161195-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct05161195-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct05161195-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-10-19. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07310420</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07310420-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07310420-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#clinicaltrials-gov-nct07310420-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-11-12. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application NDA019726</title><link>https://peptidescanner.com/stories/fda-drugs-nda019726/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-nda019726:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#fda-drugs-nda019726-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 1989-12-29. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application NDA020578</title><link>https://peptidescanner.com/stories/fda-drugs-nda020578/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-nda020578:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#fda-drugs-nda020578-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 1996-01-11. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Federal Register notice 2022-25210</title><link>https://peptidescanner.com/stories/federal-register-2022-25210/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-2022-25210:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/calcitonin-salmon.json#federal-register-2022-25210-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2022-11-18. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Federal Register notice 97-10911</title><link>https://peptidescanner.com/stories/federal-register-97-10911/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-97-10911:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#federal-register-97-10911-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 1997-04-28. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Treating relapsed epithelial ovarian cancer with luteinizing hormone-releasing agonist (goserelin) after failure of chemotherapy.</title><link>https://peptidescanner.com/stories/pubmed-pmid-12183859-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-12183859-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-12183859-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Adjuvant endocrine treatment (goserelin vs tamoxifen) in pre-menopausal patients with operable node positive stage II breast cancer. A prospective randomized national multicenter study.</title><link>https://peptidescanner.com/stories/pubmed-pmid-12217302-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-12217302-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-12217302-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-11-06. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Goserelin acetate as treatment for recurrent endometrial carcinoma: a Gynecologic Oncology Group study.</title><link>https://peptidescanner.com/stories/pubmed-pmid-12477997-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-12477997-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-12477997-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-09-06. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patien…</title><link>https://peptidescanner.com/stories/pubmed-pmid-12488405-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-12488405-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-12488405-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2016-11-02. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF).</title><link>https://peptidescanner.com/stories/pubmed-pmid-14530912-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-14530912-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-14530912-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-11-13. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.</title><link>https://peptidescanner.com/stories/pubmed-pmid-14679153-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-14679153-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-14679153-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-03-31. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-14760369-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-14760369-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-14760369-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-03-09. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Goserelin (&apos;Zoladex&apos;)--offering patients more choice in early breast cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-15590321-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-15590321-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-15590321-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-01-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>European randomized, multicenter study of goserelin (Zoladex) in the management of mastalgia.</title><link>https://peptidescanner.com/stories/pubmed-pmid-15592276-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-15592276-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-15592276-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-15668708-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-15668708-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-15668708-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-08-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Use of goserelin in the treatment of breast cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-16111461-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-16111461-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-16111461-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-16222310-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-16222310-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-16222310-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-03-16. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[Assessment of goserelin treatment in adjuvant therapy for premenopausal patients with breast cancer in Japan-zoladex breast cancer study group trial-B].</title><link>https://peptidescanner.com/stories/pubmed-pmid-16352931-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-16352931-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-16352931-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Goserelin: a review of its use in the treatment of early breast cancer in premenopausal and perimenopausal women.</title><link>https://peptidescanner.com/stories/pubmed-pmid-16392882-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-16392882-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-16392882-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-11-13. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[Hysteroresection of submucous myomas after treatment with zoladex].</title><link>https://peptidescanner.com/stories/pubmed-pmid-16637313-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-16637313-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-16637313-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93).</title><link>https://peptidescanner.com/stories/pubmed-pmid-16765589-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-16765589-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-16765589-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[Using GnRH-agonists (Zoladex) in the treatment of genital endometriosis].</title><link>https://peptidescanner.com/stories/pubmed-pmid-16889194-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-16889194-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-16889194-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Goserelin acetate in combination with radiotherapy for prostate cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-17257094-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-17257094-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-17257094-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-09-17. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Phase II trial of anastrozole plus goserelin in the treatment of hormone receptor-positive, metastatic carcinoma of the breast in premenopausal women.</title><link>https://peptidescanner.com/stories/pubmed-pmid-20679610-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-20679610-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-20679610-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-03-31. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>A Phase II trial of Zoladex combined with CEF chemotherapy as neoadjuvant therapy in premenopausal women with hormone-responsive, operable breast cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-21380781-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-21380781-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-21380781-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-01-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-21625929-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-21625929-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-21625929-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-04-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial.</title><link>https://peptidescanner.com/stories/pubmed-pmid-22265697-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-22265697-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-22265697-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-01-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate.</title><link>https://peptidescanner.com/stories/pubmed-pmid-22674191-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-22674191-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-22674191-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2014-11-20. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-22972694-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-22972694-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-22972694-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-03-09. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Preoperative endocrine therapy with goserelin acetate and tamoxifen in hormone receptor-positive premenopausal breast cancer patients.</title><link>https://peptidescanner.com/stories/pubmed-pmid-23184499-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-23184499-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-23184499-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-01-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Phase II Trial of Goserelin and Exemestane Combination Therapy in Premenopausal Women With Locally Advanced or Metastatic Breast Cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-26131799-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-26131799-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-26131799-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-03-05. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Erythema nodosum caused by goserelin acetate sustained-release: Case report and literature review.</title><link>https://peptidescanner.com/stories/pubmed-pmid-37114900-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-37114900-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-37114900-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2023-10-10. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Apalutamide and Goserelin for Androgen Receptor-Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38940667-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38940667-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-38940667-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-02-07. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[Phase Ⅲ, multicenter, randomized comparative study of LY01005 and Zoladex® for patients with premenopausal breast cancer].</title><link>https://peptidescanner.com/stories/pubmed-pmid-40268551-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-40268551-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-40268551-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-05-27. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Roles of Goserelin in Gynecological Disorders.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42226753-goserelin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42226753-goserelin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/goserelin.json#pubmed-pmid-42226753-goserelin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-08-13. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
